Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Download
Standard view
Full view
of .
Save to My Library
Look up keyword
Like this
3Activity
0 of .
Results for:
No results containing your search query
P. 1
Immunization Schedule

Immunization Schedule

Ratings:

4.0

(1)
|Views: 268 |Likes:
Published by Tracy

More info:

Published by: Tracy on Nov 03, 2008
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as DOC, PDF, TXT or read online from Scribd
See more
See less

09/09/2012

pdf

text

original

 
Table 4 - Immunizing agents and schedules for health-care workers
 
(HCWs)
1
Immunizing agentPrimary schedule and boostersHepatitis A vaccine
2
Two doses of vaccine either 6-12 monthsapart.Hepatitis B (recombinant ) vaccine
3
Two doses IM 4 weeks apart; third dose 5months after second; booster doses notnecessary.Influenza vaccine (inactivated whole-virusand split-virus vaccines)
4
Annual vaccination with current vaccine.Administered IM.Measles live-virus vaccine
5
One dose SC; second dose at least 1 monthlater.Mumps live-virus vaccine
6
One dose SC; no booster.Pneumococcal polysaccharide vaccine (23valent)
7
One dose, 0.5 ml, IM or SC; revaccinationrecommended for those at highest risk >5years after the first dose.Rubella live-virus vaccine
8
One dose SC; no booster.Tetanus and diphtheria toxoids vaccine
9
Two IM doses 4 weeks apart; third dose 6-12months after second dose; booster every 10years.Varicella-zoster vaccine
10
Two 0.5 ml doses SC 4-8 weeks apart if > 13years of age.
1
From: Immunization of Health-care workers. MMWR. December 26, 1997. 46/No.RR-18.
2
Not routinely indicated for HCWs in the United States. Persons who work with HAV-infected primates or with HAV in a research laboratory setting should be vaccinated. Thesafety of the HAV vaccine in pregnant women has not been determined.
3
On the basis of limited data, no adverse effects to developing fetuses is apparent.Pregnancy should not be considered a contraindication to vaccination of women. Thevaccine produces neither therapeutic nor adverse effects on HBV infected persons.Prevaccination serologic screening is not indicated for persons being vaccinated for occupational risk.
4
HCWs who have contact with patients at high risk for influenza or its complication; HCWswho work in chronic care facilities; HCWs who work with high-risk medical conditions or who are aged >65 years. No evidence of risk to mother or fetus when the vaccine isadministered to a pregnant woman with an underlying high risk condition. The vaccine isrecommended during the 2
nd
and 3
rd
trimesters of pregnancy because of increased for hospitalization.

Activity (3)

You've already reviewed this. Edit your review.
1 hundred reads
1 thousand reads
Jona Bruno liked this

You're Reading a Free Preview

Download
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->